Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective StudyMiao Wang, Guojiang Mei, Kepei Zhang et al.|Infection and Drug Resistance|2023Cited by 3